HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Low dose aspirin

TERMINATED · NA · Recurrent Pregnancy Loss, Antiphospholipid Antibody Syndrome

interim analysis found no difference in LB rate and lower than expected event rate

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.